Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid (Q82230939)
Jump to navigation
Jump to search
scientific article published on 09 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid |
scientific article published on 09 December 2009 |
Statements
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid (English)
J Mellergård
M Edström
M Vrethem
J Ernerudh